Young babies, asthmatics, persons with respiratory ailments, and persons who have poor immune systems are at the highest risk if they are exposed to mold. Inhalation of fungal spores and fragments may lead to allergic reactions, cause toxic effects, or cause infections. Illnesses can result from both high level, short-term exposures and lower level, long-term exposures. The most common symptoms reported from exposure to mold in indoor environments are runny nose, eye irritation, coughing, congestion, aggravation of asthma, headache and fatigue.
Presently contractors follow existing protocols and standards for mold remediation (IICRC S520 Standard). Mold is a much tougher organism to kill when compared to bacteria organisms. Aspergillus Niger is considered one of the most resilient fungal strains and is identified by the EPA as a "reference organism" for testing purposes on the Mold group. While our machine has been proven to kill mold in a laboratory setting, it is important for contractors to follow existing standards to remove both dead and living mold spores. The Odorox technology is best used to “supplement” existing protocols as follows:
The combination of accepted methods and our hydroxyl technology has further enabled contractors to achieve a successful eradication of mold.